- Home
- PASG vs CRIS Comparison
PASG vs CRIS Comparison
Compare PASG & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PASG
- CRIS
- Stock Information
- Founded
- PASG 2017
- CRIS 2000
- Country
- PASG United States
- CRIS United States
- Employees
- PASG N/A
- CRIS N/A
- Industry
- PASG Biotechnology: Pharmaceutical Preparations
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PASG Health Care
- CRIS Health Care
- Exchange
- PASG Nasdaq
- CRIS Nasdaq
- Market Cap
- PASG 20.3M
- CRIS 21.3M
- IPO Year
- PASG 2020
- CRIS 2000
- Fundamental
- Price
- PASG $6.95
- CRIS $1.83
- Analyst Decision
- PASG Strong Buy
- CRIS Strong Buy
- Analyst Count
- PASG 4
- CRIS 2
- Target Price
- PASG $59.25
- CRIS $16.50
- AVG Volume (30 Days)
- PASG 82.4K
- CRIS 64.4K
- Earning Date
- PASG 08-12-2025
- CRIS 08-05-2025
- Dividend Yield
- PASG N/A
- CRIS N/A
- EPS Growth
- PASG N/A
- CRIS N/A
- EPS
- PASG N/A
- CRIS N/A
- Revenue
- PASG N/A
- CRIS $11,405,000.00
- Revenue This Year
- PASG N/A
- CRIS N/A
- Revenue Next Year
- PASG N/A
- CRIS $9.52
- P/E Ratio
- PASG N/A
- CRIS N/A
- Revenue Growth
- PASG N/A
- CRIS 12.24
- 52 Week Low
- PASG $5.12
- CRIS $1.02
- 52 Week High
- PASG $26.60
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- PASG 53.66
- CRIS 53.34
- Support Level
- PASG $5.51
- CRIS $1.65
- Resistance Level
- PASG $6.27
- CRIS $1.79
- Average True Range (ATR)
- PASG 0.66
- CRIS 0.13
- MACD
- PASG 0.19
- CRIS 0.02
- Stochastic Oscillator
- PASG 68.76
- CRIS 84.85
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.